Advanced search
Publication Cover
The Journal of Maternal-Fetal & Neonatal Medicine Volume 32, 2019 - Issue 13
Submit an article Journal homepage
343
Views
7
CrossRef citations to date
0
Altmetric
Original Article

A diagnostic test accuracy meta-analysis of maternal serum ischemia-modified albumin for detection of preeclampsia

Varikasuvu Seshadri Reddya Department of Biochemistry, Maheshwara Medical College & Hospital, Patancheru, India; Correspondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2230-4676
ORCID Icon,
Manne Munikumarb Biomedical Informatics Center (BMIC), National Institute of Nutrition – Indian Council of Medical Research, Hyderabad, India;
,
Pragathi Dugginac Technology Business Incubator, Sri Padmavati Mahila Visvavidyalayam, Tirupati, India;
&
Neelakant Varmad Laboratory of Forensic Biology and Biotechnology, Institute of Forensic Science, Gujarat Forensic Sciences University, Gandhinagar, India
Pages 2173-2181 | Received 04 Dec 2017, Accepted 10 Jan 2018, Published online: 24 Jan 2018

References

  • Hung TH, Burton GJ. Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol. 2006;45(3): 189–200.
  • Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130–137.
  • ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol. 2002;99(1):159–167.
  • Lindheimer MD, Taler SJ, Cunningham FG. Hypertension in pregnancy. J Am Soc Hypertens. 2008;2(6):484–494.
  • Giguère Y, Charland M, Bujold E, et al. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review. Clin Chem. 2010;56(3):361–375.
  • Turner JA. Diagnosis and management of pre-eclampsia: an update. Int J Womens Health. 2010;2:327–337.
  • Cuffe JS, Xu ZC, Perkins AV. Biomarkers of oxidative stress in pregnancy complications. Biomark Med. 2017;11(3):295–306.
  • Seshadri Reddy V, Sethi S, Gupta N, et al. Significance of ischemia-modified albumin as a simple measure of oxidative stress and its discriminatory ability in diabetic retinopathy: literature Review and Meta-Analysis. Retina. 2016;36(6):1049–1057.
  • Ukinc K, Eminagaoglu S, Ersoz HO, et al. A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin. Endocrine. 2009;36(3):425–432.
  • Reddy SV, Suchitra MM, Pradeep V, et al. Ischemia-modified albumin levels in overt and subclinical hypothyroidism. J Endocrinol Invest. 2015;38(8):885–890.
  • Seshadri Reddy V, Duggina P, Vedhantam M, et al. Maternal serum and fetal cord-blood ischemia-modified albumin concentrations in normal pregnancy and preeclampsia: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2017:1–12.
  • Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3(3):25.
  • Cochrane checklist for quality of diagnostic studies [Internet]. [cited 2017 Dec 2]. Available from: http://netherlands.cochrane.org/sites/netherlands.cochrane.org/files/uploads/4.2%20Checklist%20Beoordeling%20diagnostisch%20 onderzoek.pdf
  • Bambrana V, Dayanand CD, Kotur P. Relationship between xanthine oxidase, ischemia modified albumin, nitric oxide with antioxidants in non pregnants, pre and post-delivery of normal pregnants and preeclampsia. Indian J Clin Biochem. 2017;32(2): 171–178.
  • Doğan K, Guraslan H, Çankaya A, et al. Ischemia-modified albumin (IMA): a novel marker for preeclampsia independent of uterine artery notching identified by Doppler ultrasound. Hypertens Pregnancy. 2015; 34(4):516–524.
  • Gafsou B, Lefèvre G, Hennache B, et al. Maternal serum ischemia-modified albumin: a biomarker to distinguish between normal pregnancy and preeclampsia? Hypertens Pregnancy. 2010;29(1):101–111.
  • Osmanağaoğlu MA, Caner Karahan S, Aran T, et al. Predictive value of plasma total carnitine, arginine, asymmetric dimethylarginine and ischemia-modified albumin levels and their combined use in the early detection of preeclampsia. Geburtsh Frauenheilk. 2011;71(09):773–778.
  • Ustün Y, Engin-Ustün Y, Oztürk O, et al. Ischemia-modified albumin as an oxidative stress marker in preeclampsia. J Matern Fetal Neonatal Med. 2011; 24(3):418–421.
  • Vyakaranam S, Bhongir AV, Patlolla D, et al. Maternal serum ischemia modified albumin as a marker for hypertensive disorders of pregnancy: a pilot study. Int J Reprod Contracept Obstet Gynecol. 2015;4(3): 611–616.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.